Efficacy and safety of ciprofol vs. propofol for the induction and maintenance of general anaesthesia: A multicentre, single-blind, randomised, parallel-group, phase 3 clinical trial

BACKGROUND: HSK3486 (ciprofol) is a 2,6-disubstituted phenol derivative that acts like propofol as an agonist at the gamma-aminobutyric acid-A (GABA(A)) receptor. OBJECTIVE: To investigate the efficacy and safety of HSK3486 for general anaesthesia induction and maintenance. DESIGN: A single-blinded,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Peng, Dai, Meng, Wang, Xiao, Wang, Dongxin, Yang, Mengchang, Lin, Xuemei, Zou, Xiaohua, Jiang, Ke, Li, Yalan, Wang, Liangrong, Shangguan, Wangning, Ren, Jinghua, He, Hefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Anaesthesia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155686/
https://www.ncbi.nlm.nih.gov/pubmed/36647565
http://dx.doi.org/10.1097/EJA.0000000000001799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155686/
https://www.ncbi.nlm.nih.gov/pubmed/36647565
http://dx.doi.org/10.1097/EJA.0000000000001799

Ejemplares similares